Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$2.71 - $5.9 $175,461 - $382,001
-64,746 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$4.83 - $9.67 $312,723 - $626,093
64,746 New
64,746 $320,000
Q1 2021

May 14, 2021

SELL
$6.01 - $8.9 $308,877 - $457,406
-51,394 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$5.91 - $9.11 $303,738 - $468,199
51,394 New
51,394 $304,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.